Ayurvedic Management of Diabetic Macular Oedema — DME (Sannipataja timira) — A Case Report

Authors

  • Department of Shalakya Tantra, Amrita School of Ayurveda, Kollam – 69046, Kerala
  • Anaswara Ayurvedic Hospital, Changanassery – 686106, Kerala

DOI:

https://doi.org/10.18311/jnr/2022/28782

Keywords:

Anti VEG-F, Vidalaka, Anjana Karma, Ayurveda, Proliferative Diabetic Retinopathy

Abstract

Background: Diabetic Macular Edema (DME) is the primary cause of visual loss in Diabetic Retinopathy (DR). The hyperglycemic state promotes the activation of multiple interlinked pathways leading to DME. The current guidelines in contemporary science recommend Anti VEG-F injections as the first line of treatment for this condition. Repeated Anti-VEG-F injections cause much financial burden on the patient and their family, at the cost of minimal visual outcome. From the signs and symptoms, it was diagnosed as Sannipataja timira according to Ayurveda. A 53-year-old male patient sought Ayurvedic treatment when his vision in the right eye did not improve after the injection of Accentrix for DME. His ophthalmologist advised him to repeat the injection after six months but did not assure him of complete resolution of edema. So, he opted for Ayurvedic treatment. His treatment comprised internal medicines consisting of Punarnavadi kashaya, Guduchyadi kashaya, Chandraprabha vati, Gomutra haritaki lehya; external treatments like Talpodichil with Punarnavadi churna and Pratimarsha nasya with Anu taila; Kriyakalpas (eye treatments) like Vidalaka and Anjana karma. At the end of 7.5 months of Ayurvedic treatment, his visual acuity improved from 6/60 to 6/6. Optical Coherence Tomography (OCT) affirmed the full resolution of DME. Ayurvedic treatment effectively reversed the process of macular edema, thereby bringing about marked visual outcomes in DME. Such patients shall be encouraged to go for Ayurvedic treatments, not the expensive and invasive Anti-VEGF injections.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Amoaku WM, Ghanchi F, Bailey C, Banerjee S, Banerjee S, Downey L, et al. Diabetic retinopathy and diabetic macular edema pathways and management: UK Consensus Working Group. Eye (Basingstoke). 2020. https://doi.org/10.1038/s41433-020-0961-6 PMid:32504038 PMCid:PMC7337227

Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: A review of literature. Eye (Basingstoke). 2013.

Paradakara HS. Astanga Hridaya of Vagbhatta, Uttarasthana. 9th ed.Ch. 12, Ver. 10. Varanasi: Chaukhambha Orientalia Publication; 2010. p. 817, 517 https://doi.org/10.1038/nrc2976. PMid:21155181

Ayurvedic Pharmacopoeia of India, Part 1, 2nd ed: The controller of publications civil lines Delhi; 2003. p 187, 173, 512, 91,111,133.

Sharma S. Astanga Samgraha of Vagbhatta, Utharasthana. 9th ed. Ch. 29, Ver. 8. Varanasi: Chaukhambha Orientalia Publication; 2010. p. 223.

Downloads

Published

2022-07-30

How to Cite

Shanti, K., & Remya, R. S. (2022). Ayurvedic Management of Diabetic Macular Oedema — DME (<i>Sannipataja timira</i>) — A Case Report. Journal of Natural Remedies, 22(3), 363–370. https://doi.org/10.18311/jnr/2022/28782

Issue

Section

Case Study